Home Other Building Blocks Bz-D-Ala-OH

Bz-D-Ala-OH

CAS No.:
17966-60-8
Catalog Number:
AG00276J
Molecular Formula:
C10H11NO3
Molecular Weight:
193.1992
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$15
- +
5g
98%
In Stock USA
United States
$50
- +
25g
98%
In Stock USA
United States
$188
- +
100g
98%
In Stock USA
United States
$600
- +
Product Description
Catalog Number:
AG00276J
Chemical Name:
Bz-D-Ala-OH
CAS Number:
17966-60-8
Molecular Formula:
C10H11NO3
Molecular Weight:
193.1992
MDL Number:
MFCD05155260
IUPAC Name:
(2R)-2-benzamidopropanoic acid
InChI:
InChI=1S/C10H11NO3/c1-7(10(13)14)11-9(12)8-5-3-2-4-6-8/h2-7H,1H3,(H,11,12)(H,13,14)/t7-/m1/s1
InChI Key:
UAQVHNZEONHPQG-SSDOTTSWSA-N
SMILES:
C[C@H](C(=O)O)NC(=O)c1ccccc1
Properties
Complexity:
221  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
193.074g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
193.202g/mol
Monoisotopic Mass:
193.074g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
66.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  
Literature
Title Journal
Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site. Biopharmaceutics & drug disposition 20110901
Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM). Bioorganic & medicinal chemistry 20081201
Organocatalytic asymmetric addition of alcohols and thiols to activated electrophiles: efficient dynamic kinetic resolution and desymmetrization protocols. The Journal of organic chemistry 20080815
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics. Toxicology 20060501
Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function. Chemotherapy 20060101
Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20050201
Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: detection of a new reaction intermediate and a change in rate-determining step. Biochemistry 20040323
Thermodynamic quantitative structure-activity relationship analysis for enzyme-ligand interactions in aqueous phosphate buffer and organic solvent. Bioorganic & medicinal chemistry 20010801
Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. European journal of pharmacology 20010511
Thermodynamic aspects of hydrophobicity and biological QSAR. Journal of computer-aided molecular design 20010401
Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex. Japanese journal of pharmacology 19940901
Properties